Helixtalk - Rosalind Franklin University's College Of Pharmacy Podcast

In this episode, we discuss how to excel in your next journal club presentation or discussion while avoiding the all-too-common pitfalls for this unique format.

In this episode, we will discuss some of the interesting and unusual warfarin interactions such as acetaminophen, alcohol, agents with antiplatelet properties, non-green vitamin K foods, and CBD/THC.

In this episode, we discuss the pathophysiology, drug-related causes, diagnosis, and treatment of a common type of hyponatremia called the syndrome of inappropriate antidiuretic hormone (SIADH).

In this episode, we discuss the latest dyslipidemia treatment agent bempedoic acid and dive into its pharmacology, use, and clinical evidence.

In this episode, we discuss the proposed risks of using beta blockers in patients with cocaine use disorders and whether evidence supports this drug interaction as an “absolute” contraindication.

In this episode, we dive into the pharmacology of ACE inhibitors and ARBs, particularly understanding how they assist in preserving renal function in CKD and yet at the same time can harm the kidneys (e.g. cause AKI).

In this episode, we partner with Dr. Danielle Candelario and Dr. Sneha Srivastava, clinical skills faculty at our college, to discuss tips, tricks, and common pitfalls to avoid when performing medication counseling.

In this episode, we discuss the historical significance of Staphylococcus aureus including its patterns of antimicrobial resistance and recommended treatments.

In this episode, we discuss important nutritional deficiencies as well as pharmacologic changes that occur in post-bariatric surgery patients.

In this episode, we review ten clinical pearls about total parenteral nutrition (TPN) that all pharmacists should know.

In this episode, we will discuss the most recent evidence for the use of omega-3 fatty acids (fish oil) for ASCVD risk reduction.

In this episode, we chat with Eris Tollkuci, PharmD, BCOP regarding what every non-onc healthcare provider should know about immune checkpoint inhibitors (specifically PD-1/PD-L1 inhibitors) in patients with cancer.

In this episode, we summarize some of the most significant changes in the newest version of American Diabetes Association - 2020 Standards of Medical Care in Diabetes guidelines.

In this episode, we review the pros, cons, and literature regarding the use of DOACs versus warfarin in obese patients with venous thromboembolism.

In this episode, we provide an overview of lifestyle medicine, its six pillars, and how it plays a role in improving health outcomes.

In this episode, we discuss clinical pearls and management related to chronic and acute hyperkalemia.

In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at Rosalind Franklin University’s College of Pharmacy.

In this episode, we review the three oral P2Y12 inhibitors on the market (clopidogrel, prasugrel, ticagrelor) and discuss each agent’s clinical pearls, comparative effectiveness, and unique precautions.

In this episode, we will discuss what is the latest and greatest from the GINA (Global INitiative for Asthma) 2019 guidelines, including new recommendations regarding rescue inhalers, tiotropium, and azithromycin for asthma.

In this episode, we discuss the newly published DAPA-HF trial, which studied dapagliflozin (a drug for diabetes) among patients who had heart failure with reduced ejection fraction (HFrEF) many of which did NOT have a history of diabetes.